Intensity Therapeutics, Inc. ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary cancer therapies using its non-covalent ...
The Equine Disease Communication Centre (EDCC) has reported that a case of equine strangles has been confirmed in three horses — including two Standardbreds — located in Ontario.
The global market is estimated at USD 25,900.5 million in 2025 and is forecast to reach USD 64,187.5 million by 2035, ...